Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

AMRXAMRX
23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in AMNEAL PHARMACEUTICALS INC

Bank of New York Mellon Corp holds 1M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $17.6M as of 2026-Q2. The position was increased (+11.1% shares). AMRX represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$17.6M

Current Shares

1M

Total Value Change

+$14M

Total Shares Change

+240,362

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+11.1%
$17.6M0.0%$17.31
31
2026-Q1
Increased
914,089
+84.3%
$11.4M0.0%$13.31
43
2025-Q4
Decreased
495,848
-17.4%
$6.2M0.0%$12.88
0
2025-Q3
Increased
600,203
+1.3%
$6M0.0%$9.87
27
2025-Q2
Decreased
592,821
-0.9%
$4.8M0.0%$8.13
0
2025-Q1
Decreased
598,389
-4.1%
$5M0.0%$8.28
0
2024-Q4
Decreased
623,838
-0.1%
$4.9M0.0%$7.83
0
2024-Q3
Decreased
624,732
-16.9%
$5.2M0.0%$8.19
0
2024-Q2
Increased
751,403
+20.7%
$4.8M0.0%$6.35
32
2024-Q1
Decreased
622,631
-2.0%
$3.8M0.0%$6.06
0
2023-Q4
Decreased
635,514
-7.7%
$3.9M0.0%$6.07
0
2023-Q3
Increased
688,362
+9.6%
$2.9M0.0%$4.22
29
2023-Q2
Increased
628,338
+35.6%
$1.9M0.0%$2.87
34
2023-Q1
Decreased
463,201
-5.0%
$643,8490.0%$1.36
0
2022-Q4
Decreased
487,363
-17.1%
$969,8520.0%$1.99
0
2022-Q3
Increased
587,856
+9.0%
$1.2M0.0%$2.09
28
2022-Q2
Decreased
539,330
-4.8%
$1.7M0.0%$3.32
0
2022-Q1
Increased
566,337
+1.1%
$2.4M0.0%$4.22
26
2021-Q4
Decreased
560,240
-4.2%
$2.7M0.0%$4.86
0
2021-Q3
Increased
584,843
+5.6%
$3.1M0.0%$5.50
28
2021-Q2
Decreased
553,748
-13.4%
$2.8M0.0%$5.15
0
2021-Q1
Decreased
639,543
-17.5%
$4.3M0.0%$6.66
0
2020-Q4
New
774,820
-
$3.5M0.0%$4.60
37

Other major holders of AMRX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used